221 related articles for article (PubMed ID: 35126146)
1. Tumor Necrosis Factor Alpha -308G/A Gene Polymorphisms Combined with Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratio Predicts the Efficacy and Safety of Anti-TNF-α Therapy in Patients with Ankylosing Spondylitis, Rheumatoid Arthritis, and Psoriasis Arthritis.
Wang Z; Kong L; Zhang H; Sun F; Guo Z; Zhang R; Dou Y
Front Pharmacol; 2021; 12():811719. PubMed ID: 35126146
[No Abstract] [Full Text] [Related]
2. Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratio as predictors of 12-week treatment response and drug persistence of anti-tumor necrosis factor-α agents in patients with rheumatoid arthritis: a retrospective chart review analysis.
Lee HN; Kim YK; Kim GT; Ahn E; So MW; Sohn DH; Lee SG
Rheumatol Int; 2019 May; 39(5):859-868. PubMed ID: 30874873
[TBL] [Abstract][Full Text] [Related]
3.
Iwaszko M; Wielińska J; Świerkot J; Kolossa K; Sokolik R; Bugaj B; Chaszczewska-Markowska M; Jeka S; Bogunia-Kubik K
Front Immunol; 2021; 12():631603. PubMed ID: 34177886
[TBL] [Abstract][Full Text] [Related]
4. Neutrophil-lymphocyte and platelet-lymphocyte rate and their seasonal differences in ankylosing spondylitis and rheumatoid arthritis patients using anti-TNF medication.
Enginar AU; Kacar C
Bratisl Lek Listy; 2019; 120(8):586-592. PubMed ID: 31379182
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of genetic polymorphisms in TNF‑α‑308G/A rs1800629 associated with susceptibility and severity of rheumatoid arthritis: A systematic review and meta‑analysis.
Wang YL; Li XY; Liu L; Li SF; Han PF; Li XD
Exp Ther Med; 2024 Jul; 28(1):279. PubMed ID: 38800041
[TBL] [Abstract][Full Text] [Related]
6. The value of the neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio as complementary diagnostic tools in the diagnosis of rheumatoid arthritis: A multicenter retrospective study.
Jin Z; Cai G; Zhang P; Li X; Yao S; Zhuang L; Ren M; Wang Q; Yu X
J Clin Lab Anal; 2021 Jan; 35(1):e23569. PubMed ID: 32951253
[TBL] [Abstract][Full Text] [Related]
7. Assessments of neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in Korean patients with psoriasis vulgaris and psoriatic arthritis.
Kim DS; Shin D; Lee MS; Kim HJ; Kim DY; Kim SM; Lee MG
J Dermatol; 2016 Mar; 43(3):305-10. PubMed ID: 26381893
[TBL] [Abstract][Full Text] [Related]
8. Neutrophil/lymphocyte and platelet/lymphocyte ratios as potential markers of disease activity in patients with Ankylosing spondylitis: a case-control study.
Al-Osami MH; Awadh NI; Khalid KB; Awadh AI
Adv Rheumatol; 2020 Jan; 60(1):13. PubMed ID: 32000859
[TBL] [Abstract][Full Text] [Related]
9. Platelet to lymphocyte ratio and neutrophil to lymphocyte ratio in patients with rheumatoid arthritis.
Peng YF; Cao L; Zeng YH; Zhang ZX; Chen D; Zhang Q; Zhu YS
Open Med (Wars); 2015; 10(1):249-253. PubMed ID: 28352702
[TBL] [Abstract][Full Text] [Related]
10. Two new inflammatory markers associated with Disease Activity Score-28 in patients with rheumatoid arthritis: neutrophil-lymphocyte ratio and platelet-lymphocyte ratio.
Uslu AU; Küçük A; Şahin A; Ugan Y; Yılmaz R; Güngör T; Bağcacı S; Küçükşen S
Int J Rheum Dis; 2015 Sep; 18(7):731-5. PubMed ID: 25900081
[TBL] [Abstract][Full Text] [Related]
11. Neutrophil-lymphocyte ratio, platelet-lymphocyte ratio and mean platelet volume in Japanese patients with psoriasis and psoriatic arthritis: Response to therapy with biologics.
Asahina A; Kubo N; Umezawa Y; Honda H; Yanaba K; Nakagawa H
J Dermatol; 2017 Oct; 44(10):1112-1121. PubMed ID: 28493493
[TBL] [Abstract][Full Text] [Related]
12. Association of single nucleotide polymorphism at position -308 of the tumor necrosis factor-alpha gene with ankylosing spondylitis and rheumatoid arthritis.
Manolova I; Ivanova M; Stoilov R; Rashkov R; Stanilova S
Biotechnol Biotechnol Equip; 2014 Nov; 28(6):1108-1114. PubMed ID: 26019597
[TBL] [Abstract][Full Text] [Related]
13. Comparison of Platelets-to-Lymphocyte and Neutrophil-to-Lymphocyte Ratios in Rheumatoid Arthritis and Ankylosing Spondylitis.
Khan S; Yousaf MJ; Rashid A; Manzar A
J Coll Physicians Surg Pak; 2024 Jan; 34(1):68-72. PubMed ID: 38185964
[TBL] [Abstract][Full Text] [Related]
14. Relationship between neutrophil-lymphocyte, platelet-lymphocyte ratio and disease activity in rheumatoid arthritis treated with rituximab.
Sargin G; Senturk T; Yavasoglu I; Kose R
Int J Rheum Dis; 2018 Dec; 21(12):2122-2127. PubMed ID: 30338636
[TBL] [Abstract][Full Text] [Related]
15. Effects of polymorphisms in TRAILR1 and TNFR1A on the response to anti-TNF therapies in patients with rheumatoid and psoriatic arthritis.
Morales-Lara MJ; Cañete JD; Torres-Moreno D; Hernández MV; Pedrero F; Celis R; García-Simón MS; Conesa-Zamora P
Joint Bone Spine; 2012 Dec; 79(6):591-6. PubMed ID: 22480748
[TBL] [Abstract][Full Text] [Related]
16. Meta-analysis of neutrophil-to-lymphocyte and platelet-to-lymphocyte ratio in rheumatoid arthritis.
Erre GL; Paliogiannis P; Castagna F; Mangoni AA; Carru C; Passiu G; Zinellu A
Eur J Clin Invest; 2019 Jan; 49(1):e13037. PubMed ID: 30316204
[TBL] [Abstract][Full Text] [Related]
17. High Baseline Neutrophil-to-Lymphocyte Ratio Could Serve as a Biomarker for Tumor Necrosis Factor-Alpha Blockers and Their Discontinuation in Patients with Ankylosing Spondylitis.
Moon DH; Kim A; Song BW; Kim YK; Kim GT; Ahn EY; So MW; Lee SG
Pharmaceuticals (Basel); 2023 Mar; 16(3):. PubMed ID: 36986479
[TBL] [Abstract][Full Text] [Related]
18. Role of Platelet/Lymphocyte, Neutrophil/Lymphocyte, and Interleukin-37/Interleukin-17 Ratios in the Occurrence and Treatment of Rheumatoid Arthritis.
Meng Y; Cai XL; Cong S; Sun J; Hu YW; Gu YQ; Ma XM; Luo L
Immunol Invest; 2024 Apr; 53(3):464-474. PubMed ID: 38477623
[TBL] [Abstract][Full Text] [Related]
19. Platelet/Lymphocyte, Lymphocyte/Monocyte, and Neutrophil/Lymphocyte Ratios as Biomarkers in Patients with Rheumatoid Arthritis and Rheumatoid Arthritis-Associated Interstitial Lung Disease.
Chen Q; Chen DY; Xu XZ; Liu YY; Yin TT; Li D
Med Sci Monit; 2019 Aug; 25():6474-6481. PubMed ID: 31462627
[TBL] [Abstract][Full Text] [Related]
20. The -308 tumour necrosis factor-alpha gene polymorphism predicts therapeutic response to TNFalpha-blockers in rheumatoid arthritis and spondyloarthritis patients.
Seitz M; Wirthmüller U; Möller B; Villiger PM
Rheumatology (Oxford); 2007 Jan; 46(1):93-6. PubMed ID: 16720636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
